Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inflammation01:38

Inflammation

53.9K
Overview
53.9K
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

10
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
10
T Cell Types and Functions01:24

T Cell Types and Functions

1.1K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.1K
Inflammatory Response01:28

Inflammatory Response

2.1K
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
2.1K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

12
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
12
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

51
Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
51

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

INDIVIDUAL ARTICLE: NECOM 7: Real-World Cases on Preventive and Treatment Using Skin Care for Cancer Treatment-Related Skin Reactions.

Journal of drugs in dermatology : JDD·2025
Same author

Utilization of Stem Cells in Medicine: A Narrative Review.

International journal of molecular sciences·2025
Same author

Molecular and Genetic Markers for Malignant Melanoma: Implications for Prognosis and Therapy.

Dermatopathology (Basel, Switzerland)·2025
Same author

Real World Case Series: A.G.E. Interrupter Ultra Serum.

Journal of cosmetic dermatology·2025
Same author

Real World Case Series: Integrated Skincare With Advanced RGN-6 Serum.

Journal of cosmetic dermatology·2025
Same author

OX40 and Regulatory Marker Alterations in Lesional and Non-Lesional Keloid Tissues.

Allergy·2025
Same journal

A Novel Retinoid and Salicylic Acid Topical Treatment for Moderate-Severe Acne.

Journal of drugs in dermatology : JDD·2026
Same journal

INDIVIDUAL ARTICLE: Efficacy of a Dual-Serum Cosmetic System in Women With Female Pattern Hair Loss.

Journal of drugs in dermatology : JDD·2026
Same journal

A Randomized Controlled Trial Analyzing the Likeability, Usability, and In-Use Efficacy of Mineral Sunscreens Across Diverse Skin Tones.

Journal of drugs in dermatology : JDD·2026
Same journal

Safety and Effectiveness of Two Reconstitution Volumes of Poly-L-Lactic Acid for Correction of Décolletage Wrinkles.

Journal of drugs in dermatology : JDD·2026
Same journal

Randomized Controlled Study of Bacteriophages in Acne Reveals Efficacy and Novel Mechanism for Promoting Long-Term Skin Health.

Journal of drugs in dermatology : JDD·2026
Same journal

Efficacy and Safety of Clascoterone Cream 1% and Adapalene Gel 0.3% in Patients With Acne.

Journal of drugs in dermatology : JDD·2026
See all related articles

Related Experiment Video

Updated: Jul 19, 2025

A Human Ex Vivo Atherosclerotic Plaque Model to Study Lesion Biology
05:51

A Human Ex Vivo Atherosclerotic Plaque Model to Study Lesion Biology

Published on: May 6, 2014

13.2K

Rethinking the Inflammatory Balance in Psoriasis and Atherosclerosis.

Sophie Guenin, Abrahem Kazemi, Abigail Cline

    Journal of Drugs in Dermatology : JDD
    |August 9, 2023
    PubMed
    Summary
    This summary is machine-generated.

    Psoriasis and atherosclerosis share common inflammatory pathways, suggesting a systemic link. Targeting these shared inflammatory mechanisms may offer novel therapeutic strategies for both conditions.

    More Related Videos

    Quantification of Monocyte Transmigration and Foam Cell Formation from Individuals with Chronic Inflammatory Conditions
    09:41

    Quantification of Monocyte Transmigration and Foam Cell Formation from Individuals with Chronic Inflammatory Conditions

    Published on: October 17, 2017

    13.4K
    Author Spotlight: Self-Assessment Protocol for Predicting Psoriatic Arthritis in Psoriasis Patients
    02:28

    Author Spotlight: Self-Assessment Protocol for Predicting Psoriatic Arthritis in Psoriasis Patients

    Published on: March 1, 2024

    430

    Related Experiment Videos

    Last Updated: Jul 19, 2025

    A Human Ex Vivo Atherosclerotic Plaque Model to Study Lesion Biology
    05:51

    A Human Ex Vivo Atherosclerotic Plaque Model to Study Lesion Biology

    Published on: May 6, 2014

    13.2K
    Quantification of Monocyte Transmigration and Foam Cell Formation from Individuals with Chronic Inflammatory Conditions
    09:41

    Quantification of Monocyte Transmigration and Foam Cell Formation from Individuals with Chronic Inflammatory Conditions

    Published on: October 17, 2017

    13.4K
    Author Spotlight: Self-Assessment Protocol for Predicting Psoriatic Arthritis in Psoriasis Patients
    02:28

    Author Spotlight: Self-Assessment Protocol for Predicting Psoriatic Arthritis in Psoriasis Patients

    Published on: March 1, 2024

    430

    Area of Science:

    • Dermatology and Cardiovascular Science

    Background:

    • Psoriasis and atherosclerosis are chronic inflammatory diseases with overlapping risk factors.
    • Emerging evidence suggests shared inflammatory pathways contribute to the pathogenesis of both conditions.

    Discussion:

    • The study highlights the importance of understanding the complex inflammatory milieu in both psoriasis and atherosclerosis.
    • It emphasizes the potential for cross-disciplinary research to uncover novel therapeutic targets.

    Key Insights:

    • A common inflammatory imbalance may underlie the co-occurrence of psoriasis and atherosclerosis.
    • Interleukin-17 (IL-17) and other pro-inflammatory cytokines are implicated in both diseases.
    • Targeting shared inflammatory pathways could offer a unified therapeutic approach.

    Outlook:

    • Further research is needed to elucidate the precise molecular mechanisms linking psoriasis and atherosclerosis.
    • Investigating the efficacy of systemic anti-inflammatory therapies in patients with both conditions is warranted.